146 related articles for article (PubMed ID: 31894038)
1. Clinical efficacy of nutrition support therapy combined with antibiotics in the patients of community-acquired pneumonia and its influence on serum pct and crp.
Zhou Q; Zhang L; Wang X; Wang Q; Zhang D; Yuan Y
Pak J Pharm Sci; 2019 Sep; 32(5(Special)):2477-2480. PubMed ID: 31894038
[TBL] [Abstract][Full Text] [Related]
2. The moderate predictive value of serial serum CRP and PCT levels for the prognosis of hospitalized community-acquired pneumonia.
Guo S; Mao X; Liang M
Respir Res; 2018 Oct; 19(1):193. PubMed ID: 30285748
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-5, interleukin-6, interferon induced protein-10, procalcitonin and C-reactive protein among mechanically ventilated severe community-acquired viral and bacterial pneumonia patients.
Karhu J; Ala-Kokko TI; Vuorinen T; Ohtonen P; Julkunen I; Syrjälä HT
Cytokine; 2019 Jan; 113():272-276. PubMed ID: 30055898
[TBL] [Abstract][Full Text] [Related]
4. [Impact of permissive underfeeding versus standard enteral feeding on outcomes in critical patients requiring mechanical ventilation: a prospective randomized controlled study].
Ma N; Shen M; Wan Z; Pan S; Liu X; Yao Z
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Feb; 30(2):176-180. PubMed ID: 29402370
[TBL] [Abstract][Full Text] [Related]
5. The usefulness of serum procalcitonin, C-reactive protein, soluble triggering receptor expressed on myeloid cells 1 and Clinical Pulmonary Infection Score for evaluation of severity and prognosis of community-acquired pneumonia in elderly patients.
Wang Y; Zhang S; Li L; Xie J
Arch Gerontol Geriatr; 2019; 80():53-57. PubMed ID: 30366226
[TBL] [Abstract][Full Text] [Related]
6. Influence of steroids on procalcitonin and C-reactive protein in patients with COPD and community-acquired pneumonia.
Perren A; Cerutti B; Lepori M; Senn V; Capelli B; Duchini F; Domenighetti G
Infection; 2008 Mar; 36(2):163-6. PubMed ID: 18330505
[TBL] [Abstract][Full Text] [Related]
7. Procalcitonin-Guided Antibiotic Discontinuation Might Shorten the Duration of Antibiotic Treatment Without Increasing Pneumonia Recurrence.
Akagi T; Nagata N; Wakamatsu K; Harada T; Miyazaki H; Takeda S; Ushijima S; Aoyama T; Yoshida Y; Yatsugi H; Wada K; Ueda Y; Fujita M; Watanabe K
Am J Med Sci; 2019 Jul; 358(1):33-44. PubMed ID: 31084909
[TBL] [Abstract][Full Text] [Related]
8. Impact of Procalcitonin Guidance with an Educational Program on Management of Adults Hospitalized with Pneumonia.
Walsh TL; DiSilvio BE; Hammer C; Beg M; Vishwanathan S; Speredelozzi D; Moffa MA; Hu K; Abdulmassih R; Makadia JT; Sandhu R; Naddour M; Chan-Tompkins NH; Trienski TL; Watson C; Obringer TJ; Kuzyck J; Bremmer DN
Am J Med; 2018 Feb; 131(2):201.e1-201.e8. PubMed ID: 28947168
[TBL] [Abstract][Full Text] [Related]
9. Serum Procalcitonin as A Diagnostic and Prognostic Marker for Bacterial Community - Acquired Pneumonia.
El Maghraby HM; Ismail NA; Mohammed HA
Egypt J Immunol; 2020 Jan; 27(1):37-44. PubMed ID: 33180386
[TBL] [Abstract][Full Text] [Related]
10. Utility of serum procalcitonin and C-reactive protein in severity assessment of community-acquired pneumonia in children.
Agnello L; Bellia C; Di Gangi M; Lo Sasso B; Calvaruso L; Bivona G; Scazzone C; Dones P; Ciaccio M
Clin Biochem; 2016 Jan; 49(1-2):47-50. PubMed ID: 26386341
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic efficacy of serum procalcitonin, C-reactive protein concentration and clinical pulmonary infection score in Ventilator-Associated Pneumonia.
Chen C; Yan M; Hu C; Lv X; Zhang H; Chen S
Med Sci (Paris); 2018 Oct; 34 Focus issue F1():26-32. PubMed ID: 30403171
[TBL] [Abstract][Full Text] [Related]
12. Procalcitonin, mid-regional proadrenomedullin and C-reactive protein in predicting treatment outcome in community-acquired febrile urinary tract infection.
Stalenhoef JE; van Nieuwkoop C; Wilson DC; van der Starre WE; van der Reijden TJK; Delfos NM; Leyten EMS; Koster T; Ablij HC; van 't Wout JJW; van Dissel JT
BMC Infect Dis; 2019 Feb; 19(1):161. PubMed ID: 30764769
[TBL] [Abstract][Full Text] [Related]
13. Impact of early enteral and parenteral nutrition on prealbumin and high-sensitivity C-reactive protein after gastric surgery.
Li B; Liu HY; Guo SH; Sun P; Gong FM; Jia BQ
Genet Mol Res; 2015 Jun; 14(2):7130-5. PubMed ID: 26125923
[TBL] [Abstract][Full Text] [Related]
14. The utility of serial procalcitonin measurements in addition to pneumonia severity scores in hospitalised community-acquired pneumonia: A multicentre, prospective study.
Ito A; Ito I; Inoue D; Marumo S; Ueda T; Nakagawa H; Taki M; Nakagawa A; Tatsumi S; Nishimura T; Shiota T; Ishida T
Int J Infect Dis; 2020 Mar; 92():228-233. PubMed ID: 31981766
[TBL] [Abstract][Full Text] [Related]
15. Stability in community-acquired pneumonia: one step forward with markers?
Menéndez R; Martinez R; Reyes S; Mensa J; Polverino E; Filella X; Esquinas C; Martinez A; Ramirez P; Torres A
Thorax; 2009 Nov; 64(11):987-92. PubMed ID: 19762338
[TBL] [Abstract][Full Text] [Related]
16. Markers of treatment failure in hospitalised community acquired pneumonia.
Menéndez R; Cavalcanti M; Reyes S; Mensa J; Martinez R; Marcos MA; Filella X; Niederman M; Torres A
Thorax; 2008 May; 63(5):447-52. PubMed ID: 18245147
[TBL] [Abstract][Full Text] [Related]
17. Enteral Nutrition Preparations for Blood Glucose Variability and Prognosis for Severe Acute Pancreatitis With Stress Hyperglycemia.
Zhang H; Li L; Wu J; Xu W; Wu J
Altern Ther Health Med; 2023 Jan; 29(1):163-169. PubMed ID: 36074968
[TBL] [Abstract][Full Text] [Related]
18. Procalcitonin levels are lower in intensive care unit patients with H1N1 influenza A virus pneumonia than in those with community-acquired bacterial pneumonia. A pilot study.
Piacentini E; Sánchez B; Arauzo V; Calbo E; Cuchi E; Nava JM
J Crit Care; 2011 Apr; 26(2):201-5. PubMed ID: 20813489
[TBL] [Abstract][Full Text] [Related]
19. Procalcitonin algorithm to guide initial antibiotic therapy in acute exacerbations of COPD admitted to the ICU: a randomized multicenter study.
Daubin C; Valette X; Thiollière F; Mira JP; Hazera P; Annane D; Labbe V; Floccard B; Fournel F; Terzi N; Du Cheyron D; Parienti JJ;
Intensive Care Med; 2018 Apr; 44(4):428-437. PubMed ID: 29663044
[TBL] [Abstract][Full Text] [Related]
20. Comparison of procalcitonin testing to a targeted audit-and-feedback strategy on prescribed durations of therapy for community-acquired pneumonia.
Clark LT; Beuschel TS; Buss PM; Jameson AP; Dumkow LE
Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115202. PubMed ID: 33007583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
